2. Signaling Pathways
  3. Others
  4. Drug Derivative

Drug Derivative

Drug derivative

 

Drug Derivative Related Products (291):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-137806
    Descarbamylnovobiocin
    Descarbamylnovobiocin is a derivative of Novobiocin (HY-B0425).
    Descarbamylnovobiocin
  • HY-170392
    Vasorelaxant agent-1
    Vasorelaxant agent-1 (Compound 2j) is a BBB-penatrable vasodilator. Vasorelaxant agent-1 has excellent vasodilator activity with an EC50 of 0.02916 μM. Vasorelaxant agent-1 is non-carcinogenic and can be used in the study of hypertension.
    Vasorelaxant agent-1
  • HY-49069
    Anti-osteoporosis agent-7
    		99.47%
    Anti-osteoporosis agent-7 (Compound 133) is a potential anti-osteoporosis agent showing high inhibition of osteoclast formation.
    Anti-osteoporosis agent-7
  • HY-159949
    YS10
    YS10 is a Tryptamine (HY-B2132) derivative. YS10 inhibits cell viability of SH-SY5Y cells with an IC50 of 0.44 nM.
    YS10
  • HY-P4047
    Cyclo(RGDfK(Mal))
    Cyclo(RGDfK(Mal)) is a pentapeptide. Cyclo(RGDfK(Mal)) improves the attachment and infiltration of human pluripotent stem cells. Cyclo(RGDfK(Mal)) can be used for 3D stem cell culture and expansion.
    Cyclo(RGDfK(Mal))
  • HY-169038
    11(Z),14(Z)-Eicosadienoic acid ethanolamide
    11(Z),14(Z)-Eicosadienoic acid ethanolamide (Compound 3) is an ethanolamide-conjugated form of 11(Z),14(Z)-Eicosadienoic acid (HY-149589). 11(Z),14(Z)-Eicosadienoic acid ethanolamide inhibits the inactivating transport of an endogenous cannabinoid substance with an IC50 value of 10.6 μM. 11(Z),14(Z)-Eicosadienoic acid ethanolamide can be used for research of neuropsychiatric conditions.
    11(Z),14(Z)-Eicosadienoic acid ethanolamide
  • HY-122250
    LY 288601
    LY 288601 is a potent anticancer agent.
    LY 288601
  • HY-168736
    CRC-IN-1
    CRC-IN-1 (compound (-)-15h) is a potent anti-colorectal cancer (CRC) agent, as well as a derivative of the anticancer agent Evodiamine (HY-N0114).
    CRC-IN-1
  • HY-134280
    8-Br-NHD+
    8-Br-NHD+ (Nicotinamide 8-Br-hypoxanthine dinucleotide) is a derivative of NAD+ (nicotinamide adenine dinucleotide) that acts as a potential substrate, competitive inhibitor or modulator of enzymes that interact with β-NAD+. 8-Br-NHD+ can be used to synthesize a cyclic ADP nucleotide (cADPR) analog.
    8-Br-NHD+
  • HY-129953C
    5-trans Prostaglandin F2α tromethamine
    5-trans Prostaglandin F2α tromethamine is a derivative of 5-trans Prostaglandin F2α (HY-129953A). 5-trans Prostaglandin F2α is an endogenous metabolite present in blood that can be used for the research of myocardial infarction.
    5-trans Prostaglandin F2α tromethamine
  • HY-160764
    N6-Carboxymethyl-ATP
    N6-Carboxymethyl-ATP is the alkylation product of ATP with iodoacetic acid at pH 6.5, where alkylation of ATP with iodoacetic acid at pH 6.5 yielded 1-carboxymethyl-ATP which, after alkaline rearrangement gave N6-carboxymethyl-ATP.
    N6-Carboxymethyl-ATP
  • HY-117412
    KCG 1
    KCG 1 is a potent and selective anti-tumor agent that displays anti-prollferative and cytotoxic effects on epithelial tumoral cells.
    KCG 1
  • HY-128546
    Flupranone
    Flupranone is a pyrazole derivatives with antiinflammatory and antihypertensive properties.
    Flupranone
  • HY-121702
    Dihydrohomofolic acid
    Dihydrohomofolic acid, an analog of dihydrofolic acid (H2F), might be effective against tumor in which resistance to methotrexate (MTX) is associated with high leveIs of H2F-reductase.
    Dihydrohomofolic acid
  • HY-136471
    Anticonvulsant agent 6
    Anticonvulsant agent 6 (Compound V) is a benzodiazepine compound with anticonvulsant and central depressant effects.
    Anticonvulsant agent 6
  • HY-164861
    Camptothecin analog-2
    Camptothecin analog-2 (Compound 7b-2) is a camptothecin derivative. Camptothecin analog-2 can be used in the study of cancer.
    Camptothecin analog-2
  • HY-120255
    17(R)-HDHA
    17(R)-HDHA (17(R)-HDoHE) is a pro-resolving mediator (SPM). 17(R)-HDHA enhances the differentiation of B cells toward the CD27(+)CD38(+) antibody-secreting cell phenotype, thereby strongly increasing IgM and IgG production by activated B cells. 17(R)-HDHA does not affect cell proliferation and is non-toxic to cells.
    17(R)-HDHA
  • HY-126800
    Glycotriosyl glutamine
    Glycotriosyl glutamine is a synthetic analogue of the Glycopeptide. Glycotriosyl glutamine induces focal glomerulonephritis (FGN) and the appearance of myeloid bodies in the epithelial cells of the podocytes in rats with nephritogenic activity.
    Glycotriosyl glutamine
  • HY-W205320
    β,3-Dihydroxytyrosine
    β,3-Dihydroxytyrosine is an amino acid derivative.
    β,3-Dihydroxytyrosine
  • HY-124084
    SW203668
    SW203668 is a benzothiazole compound, shows anti-tumor activity against lung cancer cell lines (IC50=0.022-0.116 μM).
    SW203668